Low-frequency subthalamic nucleus stimulation in Parkinson's disease: A randomized clinical trial

Movement Disorders

Volumn 29, Issue 2, 2014, Pages 270-274

  Khoo, Hui Ming ^a   Kishima, Haruhiko ^a   Hosomi, Koichi ^a,b   Maruo, Tomoyuki ^a,b   Tani, Naoki ^a,c   Oshino, Satoru ^a   Shimokawa, Toshio ^d   Yokoe, Masaru ^a,b   Mochizuki, Hideki ^a   Saitoh, Youichi ^a,b   Yoshimine, Toshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Otemae Hospital   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Deep brain stimulation; Low frequency stimulation; Motor function; Parkinson's disease; Subthalamic nucleus

Indexed keywords

DEEP BRAIN STIMULATION; LOW-FREQUENCY STIMULATION; MOTOR FUNCTION; PARKINSON'S DISEASE; SUBTHALAMIC NUCLEUS;

BIOPHYSICS; CROSS-OVER STUDIES; DEEP BRAIN STIMULATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; STATISTICS, NONPARAMETRIC; SUBTHALAMIC NUCLEUS;

EID: 84894273870     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25810     Document Type: Article

References (15)

1. Merola A, Zibetti M, Angrisano S, et al. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 2011;134:2074-2084.
2. Moreau C, Defebvre L, Destee A, et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 2008;71:80-84.
3. Moreau C, Pennel-Ployart O, Pinto S, et al. Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson's disease. Mov Disord 2011;26:659-663.
4. Ricchi V, Zibetti M, Angrisano S, et al. Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. Brain Stimul 2012;5:388-392.
5. Brozova H, Barnaure I, Alterman RL, Tagliati M. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease [letter]. Neurology 2009;72:770; author reply 770-771.
6. Benarroch EE. Subthalamic nucleus and its connections: anatomic substrate for the network effects of deep brain stimulation. Neurology 2008;70:1991-1995.
7. Aravamuthan BR, Muthusamy KA, Stein JF, Aziz TZ, Johansen-Berg H. Topography of cortical and subcortical connections of the human pedunculopontine and subthalamic nuclei. Neuroimage 2007;37:694-705.
8. Moore ST, MacDougall HG, Gracies JM, Ondo WG. Locomotor response to levodopa in fluctuating Parkinson's disease. Exp Brain Res 2008;184:469-478.
9. Adamiak U, Kaldonska M, Klodowska-Duda G, et al. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease. Clin Neuropharmacol 2010;33:135-141.
10. Miyai I, Fujimoto Y, Ueda Y, et al. Treadmill training with body weight support: its effect on Parkinson's disease. Arch Phys Med Rehabil 2000;81:849-852.
11. Qutubuddin AA, Pegg PO, Cifu DX, Brown R, McNamee S, Carne W. Validating the Berg Balance Scale for patients with Parkinson's disease: a key to rehabilitation evaluation. Arch Phys Med Rehabil 2005;86:789-792.
12. Leddy AL, Crowner BE, Earhart GM. Functional gait assessment and balance evaluation system test: reliability, validity, sensitivity, and specificity for identifying individuals with Parkinson disease who fall. Phys Ther 2011;91:102-113.
13. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ. The clinically important difference on the Unified Parkinson's Disease Rating Scale. Arch Neurol 2010;67:64-70.
14. Schrag A, Sampaio C, Counsell N, Poewe W. Minimal clinically important change on the Unified Parkinson's Disease Rating Scale. Mov Disord 2006;21:1200-1207.
15. Tomlinson CL, Patel S, Meek C, et al. Physiotherapy versus placebo or no intervention in Parkinson's disease [serial online]. Cochrane Database Syst Rev 2012;(8):CD002817.